Answers are grounded in this paper and cite their sources.
This study described the long-term course of EZ changes during anti-VEGF treatment in DME patients. In addition, our results underlined the potential of EZ parameters as novel OCT biomarkers for prediction of VA outcomes during therapy.
No takes yet. Share an insight, caveat, or question.
Kessler et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: